[eGongsi Notice] Exicon Signs Supply Contract Worth 6.1 Billion KRW with Samsung Electronics, etc. (Morning Summary)

[Asia Economy Reporter Hwang Yoon-joo] Exicon announced on the 24th that it has signed a semiconductor inspection equipment contract worth 6.1 billion KRW with Samsung Electronics. This accounts for 9.3% of recent sales, and the contract period is from October 21, 2022, to June 30, 2023.

▲ Platiere = Decided to acquire treasury shares worth 3 billion KRW to enhance shareholder value. The treasury share trust contract period is from October 25, 2022, to April 24, 2023.

▲ Konic Automation = Signed a supply contract for an inspection automation system worth 1.4 billion KRW with LG Chem. This is 5.24% of recent sales, and the contract period is from October 21, 2022, to July 31, 2023.

▲ PI Advanced Materials = Operating profit for Q3 was 14 billion KRW, down 26.5% compared to the same period last year. Sales were 70.2 billion KRW, down 12.5%, and net profit fell by 13.2%.

▲ POSCO ICT = Operating profit for Q3 was 16.9 billion KRW, turning to a profit compared to the same period last year. Sales increased by 11.9% to 239.4 billion KRW, and net profit turned positive to 14.9 billion KRW.

▲ C&G Hightech = Signed a semiconductor manufacturing equipment supply contract worth 53.4 billion KRW with Samsung Electronics. This accounts for 52.74% of recent sales, and the contract period is from October 21, 2022, to December 28, 2022.

▲ NI Steel = Operating profit for Q3 was 16 billion KRW, up 125.7% compared to the same period last year. Sales increased by 45.6% to 88.8 billion KRW, and net profit rose 123.2% to 11.1 billion KRW.

▲ SG&G = Announced the withdrawal of the decision to transfer the land parcels and buildings at 182 Gasa-dong, Anseong-si, Gyeonggi-do, contracted with YG Plus Development. Since the contract counterparty failed to pay the balance, the contract was canceled, and the deposit of 4 billion KRW was forfeited as a penalty.

▲ CTC Bio = Announced that the efficacy of the combination drug under development for premature ejaculation and erectile dysfunction (CDFR0812-15/50mg) was confirmed in Phase 3 clinical trials. This drug is a combination of the premature ejaculation treatment Mipramine (Condensia tablets) and the erectile dysfunction treatment Sildenafil (original product name Viagra tablets).

This content was produced with the assistance of AI translation services.